Concepedia

Author

Rhyannon Spangler

Gilead Sciences (United States)

Also Known As

Rhyannon H Spangler, Rhyannon Spangler

9

Publications

1.3K

Citations

5

H-Index

19

Concepts

All Affiliations

Gilead Sciences (United States)Technion – Israel Institute of Technology
RS

About

Rhyannon Spangler is an author at Gilead Sciences (United States) specializing in medicine, tumor microenvironment, and oxidative stress.

Top Concepts

#ConceptH-IndexPublicationsCitations

1

Medicine

3

3

1.1K

2

Immunology

2

2

279

3

Biochemistry

1

1

841

4

Biomolecular Engineering

1

1

841

5

Cell Biology

1

1

89

Rhyannon Spangler

×

5

Publications

1.3K

Citations

5

H-Index

YearCitations

Allosteric inhibition of lysyl oxidase–like-2 impedes the development of a pathologic microenvironment

Vivian Barry-Hamilton, Rhyannon Spangler, Derek Marshall,

Nature Medicine

2010

841

Selective Allosteric Inhibition of MMP9 Is Efficacious in Preclinical Models of Ulcerative Colitis and Colorectal Cancer

Derek Marshall, Susan K. Lyman, Scott McCauley,

PLoS ONE

2015

190

NFATc3 Mediates Chronic Hypoxia-induced Pulmonary Arterial Remodeling with α-Actin Up-regulation

Sergio de Frutos, Rhyannon Spangler, Dominique Alò,

Journal of Biological Chemistry

2007

106

Lysyl oxidase-like-2 promotes tumour angiogenesis and is a potential therapeutic target in angiogenic tumours

Shelly Zaffryar‐Eilot, Derek Marshall, Tali Voloshin,

Carcinogenesis

2013

89

The Role of LOX and LOXL2 in the Pathogenesis of an Experimental Model of Choroidal Neovascularization

Tine Van Bergen, Rhyannon Spangler, Derek Marshall,

Investigative Ophthalmology & Visual Science

2015

34

Page 1